No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs556816495 |
chr5:115893431-115893432 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs577360586 |
chr5:115893475-115893476 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs187973383 |
chr5:115893493-115893494 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs539693840 |
chr5:115893522-115893523 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs553206950 |
chr5:115893530-115893531 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs111245368 |
chr5:115893534-115893535 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs369920880 |
chr5:115893539-115893540 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs541789899 |
chr5:115893563-115893564 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs530693381 |
chr5:115893578-115893579 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs575582057 |
chr5:115893588-115893589 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs192801456 |
chr5:115893598-115893599 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs147892041 |
chr5:115893615-115893616 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs564468056 |
chr5:115893628-115893629 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs75171062 |
chr5:115893658-115893659 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs552409339 |
chr5:115893679-115893680 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs559652324 |
chr5:115893696-115893697 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs60190258 |
chr5:115893716-115893717 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs548217921 |
chr5:115893730-115893731 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs543100758 |
chr5:115893760-115893761 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs78289681 |
chr5:115893782-115893783 |
Flanking Active TSS Weak transcription Enhancers Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs548012241 |
chr5:115893808-115893809 |
Enhancers Weak transcription Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs184844128 |
chr5:115893812-115893813 |
Enhancers Weak transcription Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs369531944 |
chr5:115893913-115893914 |
Enhancers Weak transcription Genic enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs559942934 |
chr5:115893998-115893999 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs190116544 |
chr5:115894008-115894009 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs570459580 |
chr5:115894019-115894020 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs530318844 |
chr5:115894046-115894047 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs539607101 |
chr5:115894082-115894083 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs200809850 |
chr5:115894149-115894150 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs375971715 |
chr5:115894150-115894151 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs369006905 |
chr5:115894151-115894152 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs12658703 |
chr5:115894220-115894221 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs569922940 |
chr5:115894221-115894222 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs566749337 |
chr5:115894271-115894272 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs1700486 |
chr5:115894438-115894439 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs181708865 |
chr5:115894451-115894452 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs377100610 |
chr5:115894454-115894455 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs369614232 |
chr5:115894455-115894456 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs372734789 |
chr5:115894456-115894457 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs199824220 |
chr5:115894457-115894458 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs578155629 |
chr5:115894493-115894494 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs545993283 |
chr5:115894539-115894540 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs254210 |
chr5:115894566-115894567 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs254209 |
chr5:115894579-115894580 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs542100743 |
chr5:115894588-115894589 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs147896492 |
chr5:115894595-115894596 |
Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs530481002 |
chr5:115894652-115894653 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs550318169 |
chr5:115894663-115894664 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs570181915 |
chr5:115894700-115894701 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs141563898 |
chr5:115894702-115894703 |
Flanking Active TSS Weak transcription Enhancers
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|